Actively Recruiting
Prospective Cohort Study on Risk Factors and Machine Learning-Based Prediction of Postoperative Venous Thromboembolism in Patients Undergoing Lung Cancer Surgery
Led by The First Hospital of Jilin University · Updated on 2026-02-27
900
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are investigating risk factors and prediction of postoperative venous thromboembolism (VTE), specifically deep vein thrombosis (DVT), in patients undergoing lung cancer surgery. The goal is to understand which clinical, surgical, and laboratory factors contribute to developing DVT after surgery and to evaluate if machine learning models can accurately predict individual risk. This observational study follows participants for 30 days after their lung cancer surgery. The study involves collecting perioperative clinical data, laboratory results, and imaging findings from adult patients who have lung cancer surgery. Participants are grouped based on whether they develop postoperative DVT within 30 days or not. The collected data will help identify risk factors and create predictive models using machine learning techniques. No treatment beyond standard care is provided as part of this data collection. During the study, participants' clinical, laboratory, and imaging data will be recorded, and the occurrence of postoperative DVT will be monitored for 30 days after surgery. Researchers will analyze these data to identify risk factors and measure the incidence of DVT. Participants will be followed closely for at least 48 hours post-surgery and during the 30-day follow-up period. The study aims to improve understanding and prediction of VTE risk in lung cancer surgery patients.
CONDITIONS
Brief Title
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Undergoing surgical resection for lung cancer
- Postoperative hospital stay of 48 hours or more
- Availability of perioperative clinical, laboratory, and imaging data
- Willingness to provide informed consent and participate in 30-day follow-up
You will not qualify if you...
- Pre-existing deep vein thrombosis (DVT) or pulmonary embolism (PE) before surgery
- Preoperative or ongoing anticoagulation therapy for 2 weeks or longer
- Severe coagulation disorders or bleeding diseases
- Severe liver, kidney, or blood disorders, or uncontrolled systemic infection
- Undergoing major organ surgery other than lung cancer surgery
- Pregnancy or breastfeeding
- Incomplete postoperative follow-up data
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Hospital stay of 48 hours or more
Participants undergo lung cancer surgery and receive standard post-operative care. Clinical, laboratory, and imaging data are collected during this period.
Hospitalization period with continuous monitoring
Duration - 30 days postoperatively
Participants are observed for up to 30 days after surgery to monitor for the occurrence of deep vein thrombosis (DVT) and to collect perioperative risk factor data.
Approximately 1 to 2 follow-up visits within 30 days
Trial Site Locations
Total: 1 location
1
The First Hospital of Jilin University, Department of Thoracic Surgery
Changchun, Jilin, China, 130021
Actively Recruiting
Research Team
W
Wei Liu
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here